Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) EBT Margin (2018 - 2026)

Insmed's EBT Margin history spans 12 years, with the latest figure at 52.98% for Q1 2026.

  • Quarterly EBT Margin rose 22246.0% to 52.98% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 143.76% through Mar 2026, up 12111.0% year-over-year, with the annual reading at 209.71% for FY2025, 4051.0% up from the prior year.
  • EBT Margin came in at 52.98% for Q1 2026, up from 123.91% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 52.98% in Q1 2026 to a low of 331.83% in Q2 2024.
  • The 5-year median for EBT Margin is 224.32% (2024), against an average of 222.13%.
  • Year-over-year, EBT Margin plummeted -17043bps in 2023 and then soared 22246bps in 2026.
  • Insmed's EBT Margin stood at 269.81% in 2022, then rose by 18bps to 221.12% in 2023, then decreased by -1bps to 224.32% in 2024, then soared by 45bps to 123.91% in 2025, then surged by 57bps to 52.98% in 2026.
  • Per Business Quant, the three most recent readings for INSM's EBT Margin are 52.98% (Q1 2026), 123.91% (Q4 2025), and 259.02% (Q3 2025).